Return to Home Incidence > Table

Incidence Rates Table

Data Options
Comparison Options

Incidence Rate Report by State

Pancreas (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name

State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 9.9 (9.9, 10.0) N/A 41,472 72.9
Wyoming 2 8.5 (7.6, 9.6) 47 (21, 51) 64 72.8
Wisconsin 2 10.7 (10.3, 11.0) 12 (3, 21) 842 72.4
West Virginia 2 10.5 (9.9, 11.1) 15 (2, 31) 273 75.6
Washington 1 10.7 (10.4, 11.0) 11 (3, 21) 993 78.1
Virginia 2 8.9 (8.6, 9.1) 42 (36, 47) 955 68.0
Vermont 2 9.4 (8.6, 10.4) 33 (6, 49) 88 72.5
Utah 7 8.6 (8.1, 9.1) 45 (35, 50) 252 71.5
Texas 7 9.4 (9.3, 9.6) 34 (27, 40) 2,849 69.9
Tennessee 2 8.8 (8.5, 9.1) 44 (36, 48) 770 67.3
South Dakota 2 10.2 (9.4, 11.1) 19 (1, 42) 115 76.5
South Carolina 2 9.7 (9.3, 10.0) 28 (20, 39) 677 71.4
Rhode Island 2 10.2 (9.5, 11.0) 20 (2, 39) 149 74.1
Puerto Rico 2 5.2 (4.9, 5.5) N/A 260 62.1
Pennsylvania 2 10.8 (10.5, 11.0) 9 (3, 17) 1,965 74.6
Oregon 2 9.2 (8.8, 9.5) 40 (28, 46) 521 71.6
Oklahoma 2 8.8 (8.5, 9.2) 43 (32, 48) 429 71.1
Ohio 2 10.1 (9.9, 10.4) 23 (14, 28) 1,590 72.1
North Dakota 2 9.5 (8.6, 10.5) 31 (5, 49) 90 76.3
North Carolina 2 10.6 (10.3, 10.8) 14 (4, 22) 1,405 75.0
New York 7 10.9 (10.7, 11.1) 5 (2, 14) 2,844 76.0
New Mexico 7 7.4 (6.9, 7.9) 51 (49, 51) 212 62.8
New Jersey 7 11.2 (10.9, 11.5) 3 (1, 10) 1,330 74.2
New Hampshire 2 9.5 (8.9, 10.1) 32 (15, 46) 190 69.9
Nevada 2 7.8 (7.4, 8.2) 50 (47, 51) 302 63.6
Nebraska 2 9.2 (8.7, 9.8) 38 (21, 48) 222 70.4
Montana 2 9.4 (8.7, 10.1) 35 (15, 48) 143 73.5
Missouri 2 10.1 (9.8, 10.4) 24 (12, 32) 812 73.3
Mississippi 2 10.1 (9.7, 10.6) 22 (6, 34) 379 73.3
Minnesota 2 9.5 (9.2, 9.8) 30 (23, 41) 685 66.9
Michigan 2 10.6 (10.3, 10.8) 13 (4, 22) 1,431 73.3
Massachusetts 2 10.3 (10.0, 10.6) 18 (8, 28) 942 73.7
Maryland 2 9.9 (9.6, 10.2) 25 (16, 34) 762 72.7
Maine 2 9.6 (9.0, 10.3) 29 (11, 45) 207 67.9
Louisiana 7 11.6 (11.2, 12.0) 1 (1, 5) 659 78.4
Kentucky 7 10.8 (10.4, 11.2) 7 (2, 21) 624 76.0
Kansas 2 9.2 (8.8, 9.7) 37 (23, 47) 333 75.4
Iowa 7 10.8 (10.4, 11.3) 6 (1, 22) 453 77.9
Indiana 2 10.4 (10.1, 10.7) 17 (6, 26) 875 73.8
Illinois 7 10.7 (10.5, 11.0) 10 (3, 19) 1,706 74.7
Idaho 7 10.2 (9.6, 10.8) 21 (3, 37) 228 75.9
Hawaii 7 9.8 (9.1, 10.4) 27 (8, 43) 199 76.1
Georgia 7 10.8 (10.5, 11.1) 8 (2, 18) 1,317 78.4
Florida 2 9.9 (9.7, 10.0) 26 (20, 31) 3,240 72.5
District of Columbia 2 11.0 (9.9, 12.2) 4 (1, 36) 74 67.0
Delaware 2 10.5 (9.7, 11.3) 16 (1, 37) 151 73.5
Connecticut 7 11.3 (10.9, 11.7) 2 (1, 13) 553 77.0
Colorado 2 8.5 (8.2, 8.9) 46 (39, 49) 561 72.7
California 7 9.3 (9.2, 9.4) 36 (30, 41) 4,234 73.7
Arkansas 2 9.2 (8.8, 9.6) 39 (26, 46) 361 69.2
Arizona 2 8.5 (8.2, 8.8) 48 (40, 49) 822 69.0
Alaska 2 9.1 (8.1, 10.1) 41 (12, 51) 70 71.1
Alabama 2 8.1 (7.8, 8.4) 49 (44, 51) 538 62.1

Notes:
Created by statecancerprofiles.cancer.gov on 02/18/2026 9:50 pm.

State Cancer Registries may provide more current or more local data.

Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.


† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. The rates used in CI*Rank are all age-adjusted to the 2000 US standard population using 19 age groups for SEER and NPCR areas. More information about methodology can be found on the CI*Rank website.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2024 submission.

2 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2024 submission).

7 Source: SEER November 2024 submission.

Data for United States does not include Puerto Rico.

CI*Rank data for Puerto Rico is not available.

Return to Top